ERICA HICKERSON: Open Payments
NPI 1275560336 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,986 in 85 payments from 23 companies in 2025. Trend: 2023 $2,142 · 2024 $1,153 · 2025 $1,986
Food & beverage: $1,986
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $311 |
| GlaxoSmithKline, LLC. | 10 | $286 |
| Novo Nordisk Inc | 11 | $277 |
| ABBVIE INC. | 14 | $272 |
| Hologic Sales and Service, LLC | 1 | $124 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $118 |
| Lilly USA, LLC | 6 | $109 |
| Abbott Laboratories | 3 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $49 |
Products named: BREZTRI, Wegovy, PENMENVY, CREON, APTIMA, CAPLYTA, QULIPTA, TRELEGY ELLIPTA.
Industry payments across KS — which companies pay providers there.
